Halozyme intends to purchase all the shares of Evotec at 11 euros per share, which represents a premium of 27.5% to Evotec's last close price. U.S.-listed shares of Evotec were up 6.3%, while those of ...
German drugmaker Evotec is attracting takeover interest from U.S.-based Halozyme Therapeutics , Bloomberg News reported on Thursday.
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
The Series D financing will support the clinical development of two ADCs.
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...
The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback